- 1D
- 3D
- 1W
- 1M
- 6M
- 1Y
- 3Y
- 5Y
Announcements
- Significant POLB 001 Patent Granted in USA
- Appointment of Joint Broker
- Option Agreement to Acquire Orphan Drug Candidate
- Results for the year ended 31 December 2023
- TR-1: Notification of major holdings
- POLB 001 US Patent Update
- Director/PDMR Shareholding
- Director Share Purchase
- Board Role Change and Launch of EIP
- Market Opportunity for POLB 001 for CRS
More ▼
Key statistics
As of last trade Poolbeg Pharma PLC (POLB:LSE) traded at 13.90, -11.84% below its 52-week high of 15.77, set on May 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 14.05 |
---|---|
High | 14.20 |
Low | 13.90 |
Bid | 13.80 |
Offer | 13.90 |
Previous close | 14.05 |
Average volume | 4.56m |
---|---|
Shares outstanding | 500.00m |
Free float | 386.69m |
P/E (TTM) | -- |
Market cap | 70.25m GBP |
EPS (TTM) | -0.0079 GBP |
Data delayed at least 20 minutes, as of May 09 2024 10:37 BST.
More ▼